BARCLAYS PLC - HAEMONETICS CORP MASS ownership

HAEMONETICS CORP MASS's ticker is and the CUSIP is 405024AB6. A total of 49 filers reported holding HAEMONETICS CORP MASS in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of HAEMONETICS CORP MASS
ValueSharesWeighting
Q3 2023$134
-26.0%
154,000
-27.0%
0.00%
Q2 2023$181
-77.3%
211,000
-77.5%
0.00%
Q1 2023$797
-44.5%
936,000
-45.8%
0.00%
-100.0%
Q4 2022$1,437
-98.2%
1,726,000
+1626.0%
0.00%
Q3 2022$80,000100,0000.00%
Other shareholders
HAEMONETICS CORP MASS shareholders Q1 2023
NameSharesValueWeighting ↓
OSTERWEIS CAPITAL MANAGEMENT INC 18,000,000$15,705,0001.15%
Context Capital Management, LLC 14,558$12,6601.02%
Quaero Capital S.A. 1,200,000$1,042,4400.99%
READYSTATE ASSET MANAGEMENT LP 22,200,000$19,369,5000.97%
DeepCurrents Investment Group LLC 24,371,000$21,212,5170.92%
ADVENT CAPITAL MANAGEMENT /DE/ 39,904,000$34,816,2400.81%
SSI INVESTMENT MANAGEMENT LLC 10,872,000$9,431,4620.77%
Empyrean Capital Partners, LP 13,500,000$11,696,9590.72%
MACKAY SHIELDS LLC 29,294,000$25,825,1100.71%
Aequim Alternative Investments LP 20,500,000$17,886,2500.68%
View complete list of HAEMONETICS CORP MASS shareholders